Michael Chambers's most recent trade in Sarepta Therapeutics Inc was a trade of 4,792 Stock Options (right to buy) done . Disclosure was reported to the exchange on March 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics Inc | Michael A. Chambers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 4,792 | 4,792 | - | - | Stock Options (right to buy) | |
| Sarepta Therapeutics Inc | Michael A. Chambers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 2,383 | 10,660 (0%) | 0% | - | Common Stock | |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 134.06 per share. | 16 Aug 2024 | 18,284 | 278,386 (0%) | 0% | 134.1 | 2,451,153 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 133.07 per share. | 16 Aug 2024 | 13,106 | 260,102 (0%) | 0% | 133.1 | 1,744,015 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 134.66 per share. | 16 Aug 2024 | 5,648 | 284,034 (0%) | 0% | 134.7 | 760,560 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 3,679 | 3,679 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,846 | 8,277 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 109.19 per share. | 14 Aug 2023 | 5,947 | 242,964 (0%) | 0% | 109.2 | 649,353 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 109.89 per share. | 14 Aug 2023 | 4,032 | 246,996 (0%) | 0% | 109.9 | 443,076 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 108.05 per share. | 11 Aug 2023 | 23,686 | 237,017 (0%) | 0% | 108.0 | 2,559,272 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 106.26 per share. | 10 Aug 2023 | 31,570 | 213,331 (0%) | 0% | 106.3 | 3,354,628 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 104.67 per share. | 10 Aug 2023 | 2,206 | 180,670 (0%) | 0% | 104.7 | 230,902 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 105.90 per share. | 10 Aug 2023 | 1,091 | 181,761 (0%) | 0% | 105.9 | 115,537 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 3,257 | 3,257 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 1,523 | 6,431 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 104.67 per share. | 14 Sep 2022 | 30,106 | 101,928 (0%) | 0% | 104.7 | 3,151,195 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 103.87 per share. | 14 Sep 2022 | 20,744 | 71,822 (0%) | 0% | 103.9 | 2,154,679 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 105.16 per share. | 14 Sep 2022 | 6,250 | 108,178 (0%) | 0% | 105.2 | 657,250 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 108.20 per share. | 19 Aug 2022 | 40,110 | 45,018 (0%) | 0% | 108.2 | 4,339,902 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Purchase of securities on an exchange or from another person at price $ 108.80 per share. | 19 Aug 2022 | 6,060 | 51,078 (0%) | 0% | 108.8 | 659,328 | Common Stock |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 8,329 | 8,329 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | Michael Chambers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 4,908 | 4,908 (0%) | 0% | 0 | Common Stock |